[HTML][HTML] First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

…, F Riccardo, E Nicastri, I Casas, A Larrauri… - …, 2020 - eurosurveillance.org
In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020.
We detail the first European cases. As at 21 February, nine European countries reported 47 …

[PDF][PDF] Exceso de mortalidad relacionado con la gripe en España en el invierno de 2012

…, F Simón, D Gómez-Barroso, A Larrauri… - Gaceta …, 2015 - SciELO Public Health
Objetivo: El sistema de monitorización de la mortalidad diaria en España y el programa
European monitoring of excess mortality for public health action detectaron un exceso de …

Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study

…, JF Muñoz-Montalvo, F Blanco, A Larrauri… - Bmj, 2020 - bmj.com
Objective To estimate the infection fatality risk for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), based on deaths with confirmed coronavirus disease 2019 (covid-19) …

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

…, C Delgado-Sanz, S de mateo Ontañón, A Larrauri… - The Lancet, 2018 - thelancet.com
Background Estimates of influenza-associated mortality are important for national and
international decision making on public health priorities. Previous estimates of 250 000–500 000 …

[HTML][HTML] Excess all-cause mortality during the COVID-19 pandemic in Europe–preliminary pooled estimates from the EuroMOMO network, March to April 2020

…, SP da Silva, AP Rodrigues, A Larrauri… - …, 2020 - eurosurveillance.org
A remarkable excess mortality has coincided with the COVID-19 pandemic in Europe. We
present preliminary pooled estimates of all-cause mortality for 24 European countries/federal …

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain

A Larrauri, R Cano, M García, S De Mateo - Vaccine, 2005 - Elsevier
This study describes the epidemiological impact of meningococcal C conjugate vaccine on
age groups targeted by this vaccination programme in Spain, and estimates high short-term …

[HTML][HTML] Regional excess mortality during the 2020 COVID-19 pandemic in five European countries

…, IL Gómez, M Pirani, G Baio, A Larrauri… - Nature …, 2022 - nature.com
The impact of the COVID-19 pandemic on excess mortality from all causes in 2020 varied
across and within European countries. Using data for 2015–2019, we applied Bayesian spatio-…

Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B. 1.1. 529) variant in Spain: a nationwide cohort study

…, A Limia, E Martín-Merino, A Larrauri… - The Lancet Infectious …, 2022 - thelancet.com
Background The omicron (B.1.1.529) variant of SARS-CoV-2 has increased capacity to
elude immunity and cause breakthrough infections. The aim of this study was to estimate the …

[HTML][HTML] Low and decreasing vaccine effectiveness against influenza A (H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE …

E Kissling, M Valenciano, A Larrauri, B Oroszi… - …, 2013 - eurosurveillance.org
Eurosurveillance | Low and decreasing vaccine effectiveness against influenza A(H3) in
2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case–…

A surveillance network for meningococcal disease in Europe

…, M Chandra, R Cano, A Larrauri… - FEMS microbiology …, 2007 - academic.oup.com
Between 1999 and 2004, the European Union Invasive Bacterial Infections Surveillance
Network (EU-IBIS) received c . 50 000 reports of meningococcal disease from 27 participating …